acetylglucosamine has been researched along with Myocardial Infarction in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jaggi, AS; Singh, N; Tyagi, S; Virdi, JK | 1 |
| Bøtker, HE; Hjortbak, MV; Jensen, RV; Jespersen, NR; Johnsen, J; Kristiansen, SB; Pryds, K; Pælestik, KB | 1 |
| Brown, M; Che, P; Davis, ME; Gray, WD; Murthy, N; Ning, X | 1 |
| Levit, RD; Taylor, WR | 1 |
| Buus Kristiansen, S; Bøtker, HE; Johnsen, J; Vibjerg Jensen, R; Zachara, NE | 1 |
1 review(s) available for acetylglucosamine and Myocardial Infarction
| Article | Year |
|---|---|
Diabetes abolish cardioprotective effects of remote ischemic conditioning: evidences and possible mechanisms.
Topics: Acetylglucosamine; AMP-Activated Protein Kinases; Animals; Arginase; Autophagy; Beclin-1; Diabetes Mellitus, Type 2; Gene Expression Regulation; Humans; Ischemic Preconditioning, Myocardial; Myocardial Infarction; Myocardial Reperfusion Injury; Nitric Oxide; Oxidative Stress; Phosphatidylinositol 3-Kinase; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; rho-Associated Kinases; Signal Transduction; TOR Serine-Threonine Kinases | 2019 |
4 other study(ies) available for acetylglucosamine and Myocardial Infarction
| Article | Year |
|---|---|
Impact of hyperglycemia on myocardial ischemia-reperfusion susceptibility and ischemic preconditioning in hearts from rats with type 2 diabetes.
Topics: Acetylglucosamine; Animals; beta-N-Acetylhexosaminidases; Biomarkers; Blood Glucose; Diabetes Mellitus, Type 2; Disease Models, Animal; Ischemic Preconditioning, Myocardial; Isolated Heart Preparation; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Rats, Zucker | 2019 |
N-acetylglucosamine conjugated to nanoparticles enhances myocyte uptake and improves delivery of a small molecule p38 inhibitor for post-infarct healing.
Topics: Acetylglucosamine; Animals; Cardiovascular Agents; Drug Carriers; Imidazoles; Myocardial Infarction; Myocardium; Nanoparticles; p38 Mitogen-Activated Protein Kinases; Polymers; Protein Kinase Inhibitors; Pyrimidines | 2011 |
A clinical commentary on the article "N-acetylglucosamine conjugated to nanoparticles enhances myocyte uptake and improves delivery of a small molecule p38 inhibitor for post-infarct healing" : N-acetylglucosamine conjugated nanoparticles: translational o
Topics: Acetylglucosamine; Animals; Cardiovascular Agents; Chemistry, Pharmaceutical; Disease Models, Animal; Drug Carriers; Drug Compounding; Imidazoles; Myocardial Infarction; Myocardium; Nanoparticles; p38 Mitogen-Activated Protein Kinases; Polymers; Protein Kinase Inhibitors; Pyrimidines; Regeneration | 2011 |
Ischemic preconditioning increases myocardial O-GlcNAc glycosylation.
Topics: Acetylglucosamine; Alloxan; Animals; Azaserine; Disease Models, Animal; Glycosylation; Hemodynamics; Ischemic Preconditioning, Myocardial; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; N-Acetylglucosaminyltransferases; Rats; Rats, Wistar; Recovery of Function; Time Factors; Up-Regulation | 2013 |